Investments, Equity Method and Joint Ventures (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Dec. 02, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2025 |
|
| Schedule of Equity Method Investments [Line Items] | ||||
| Payments to Acquire Investments | $ 0 | $ 44,900 | ||
| Equity Method Investments | 63,888 | $ 59,662 | ||
| Income (Loss) from Equity Method Investments | $ 4,226 | $ 0 | ||
| CB&I | ||||
| Schedule of Equity Method Investments [Line Items] | ||||
| Payments to Acquire Investments | $ 44,900 | |||
| Equity Method Investment, Ownership Percentage | 12.50% | |||
| Equity Method Investments | $ 63,888 | |||
| Income (Loss) from Equity Method Investments | $ (4,226) | |||
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of all investments (debt, security, other) during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|